Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
0.4838
-0.0662 (-12.04%)
At close: Aug 13, 2025, 4:00 PM
0.4600
-0.0238 (-4.92%)
Pre-market: Aug 14, 2025, 9:19 AM EDT
Salarius Pharmaceuticals Market Cap
Salarius Pharmaceuticals has a market cap or net worth of $1.03 million as of August 14, 2025. Its market cap has decreased by -53.22% in one year.
Market Cap
1.03M
Enterprise Value
234.30K
1-Year Change
-53.22%
Ranking
Category
Stock Price
$0.48
Market Cap Chart
Since January 29, 2015, Salarius Pharmaceuticals's market cap has decreased from $254.40M to $1.03M, a decrease of -99.60%. That is a compound annual growth rate of -40.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 3.70M | 37.04% |
| Dec 31, 2024 | 2.70M | 3.85% |
| Dec 29, 2023 | 2.60M | -25.71% |
| Dec 30, 2022 | 3.50M | -84.38% |
| Dec 31, 2021 | 22.40M | 23.76% |
| Dec 31, 2020 | 18.10M | 17.53% |
| Dec 31, 2019 | 15.40M | 156.67% |
| Dec 31, 2018 | 6.00M | -90.43% |
| Dec 29, 2017 | 62.70M | -33.93% |
| Dec 30, 2016 | 94.90M | -57.52% |
| Dec 31, 2015 | 223.40M | -12.19% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |